[Peroperative thromboembolism prophylaxis: low-dose heparin or low molecular weight heparin-DHE, the advantages and disadvantages. A prospective randomized study].
Hoffmann
R
R
Largiadèr
F
F
Roethlin
M
M
D002986:Clinical Trials as Topic; D004087:Dihydroergotamine / Q000008:administration & dosage*; D004338:Drug Combinations / Q000008:administration & dosage; D006493:Heparin / Q000008:administration & dosage*; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage*; D006801:Humans; D007431:Intraoperative Complications / Q000517:prevention & control*; D011446:Prospective Studies; D011655:Pulmonary Embolism / Q000517:prevention & control; D011897:Random Allocation; D013923:Thromboembolism / Q000517:prevention & control*
D004338:Drug Combinations; D006495:Heparin, Low-Molecular-Weight; C031388:heparin-dihydergot; D004087:Dihydroergotamine; D006493:Heparin
Perioperative Thromboembolie-Prophylaxe: niedrig dosiertes Heparin oder low molecular Heparin-DHE, Vor- und Nachteile. Eine prospektive, randomisierte Untersuchung.